Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
STRIASCAN Inj Lös 74 MBq/ml Durchstf 2.5 ml
Drug
Striascan 74 MBq/ml, Injektionslösung
Untersuchung dopaminerger Neuronenendigungen im Striatum von Patienten mit klinisch unklaren Parkinson-Symptomen
17.01.1. – centralnervous system
HAM – Human medicine
LSINJ – Solution for injection
R – radiopharmaceutic products
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
9/9/2022
9/8/2027
Dosage strength
Striascan 74 MBq/ml, Injektionslösung
Untersuchung dopaminerger Neuronenendigungen im Striatum von Patienten mit klinisch unklaren Parkinson-Symptomen
01
Z – approved
Package
7680685930019
In trade from / since 9/9/2022
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
185 MBq ioflupanum(123-I)
ioflupanum(127-I)
98.75 mg ethanolum
acidum aceticum
natrii acetas trihydricus
4.9 mg natrium
acidum phosphoricum concentratum
aqua ad iniectabile
98.75 mg ethanolum
acidum aceticum
natrii acetas trihydricus
4.9 mg natrium
acidum phosphoricum concentratum
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
891.85
None
Yes
10%
Yes
Authorisation holder
7601001401525
b.e.imaging.ag
Strehlgasse 9
6430 Schwyz (SZ)
Strehlgasse 9
6430 Schwyz (SZ)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.